Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Journal of Virology|December 30, 2016
Barriers to Infection of Human Cells by Feline Leukemia Virus: Insights into Resistance to ZoonosisAnne Terry, Anna Kilbey, Asif Naseer, et al.Oncotarget|April 9, 2016
Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma modelGillian Borland, Anna Kilbey, Jodie Hay, et al.Viruses|April 28, 2015
Frequent infection of human cancer xenografts with murine endogenous retroviruses in vivoAsif Naseer, Anne Terry, Kathryn Gilroy, et al.Journal of Cellular Biochemistry|October 21, 2017
RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteinsGail Anderson, Nancy Mackay, Kathryn Gilroy, et al.Oncogene|May 11, 2004
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53Sandy F Wotton, Karen Blyth, Anna Kilbey, et al.Journal of Virology|January 15, 2005
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of EnvMargaret J Hosie, Dieter Klein, James M Binley, et al.Plos One|April 21, 2016
Gamma-Retrovirus Integration Marks Cell Type-Specific Cancer Genes: A Novel Profiling Tool in Cancer GenomicsKathryn L Gilroy, Anne Terry, Asif Naseer, et al.Scientific Reports|October 23, 2015
Runx2 contributes to the regenerative potential of the mammary epitheliumNicola Ferrari, Alessandra I Riggio, Susan Mason, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2009
A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of gammaC gene oncogenicityLinda Scobie, Ralph D Hector, Louise Grant, et al.Vaccine|February 23, 2002
Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18Stephen P Dunham, J Norman Flynn, Mark A Rigby, et al.Pageof 4